We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Reflecting on Norovirus Outbreaks May Help Guide Vaccine Development

Study confirms several factors that can make norovirus outbreaks more severe and may help guide efforts to develop a vaccine to prevent this highly contagious disease.
News

Treatment for Canine Leishmaniasis Exists in Brazilian Vaccine

Canine leishmaniasis, typically transmitted by sand fly bites, can cause skin sores, weight loss, blindness and kidney failure.
News

'Bubble Baby' Study Calls for Neonatal Screening

As therapeutic options become more advanced, the case for neonatal screening strengthens.
News

Machine-learning System Could Aid Critical Decisions in Sepsis Care

This predictive model could guide clinicians in deciding when to give potentially life-saving drugs to patients being treated for sepsis in the emergency room.
News

Non-circulating T Cells Vital for Protection against Salmonella

Noncirculating T cells are relatively unknown, but appear to be a vital component of immunity to Salmonella infection — and should be the focus of vaccine strategies.
News

Revealed: How Deadly Pneumococcus Suppresses Immune Defenses

Scientists have discovered a new and important function of a toxin produced by disease-causing bacteria that could have significant implications for future vaccine design.
News

Personalized Implants Designed to Improve Organ Transplant Success

A versatile bioengineering approach has been created to improve organ transplant success. By using host-derived scaffolding material, there is less chance of immune rejection.
News

Nanoscaffold Developed to Enhance CNS Stem Cell Therapy

Biodegradable nanoscaffolds have been developed to overcome a host of challenges in stem cell therapies for CNS diseases and injuries
News

Promising Marker for Immune Invasion and Immunotherapy Failure

An extracellular matrix gene signature has been identified which is associated with response to immunotherapy, and provides a hypothesis about why some people don't respond.
News

Chemo-Immunotherapy Combo Effective for Leukemia in Phase II

An encouraging response rate and overall survival has been reported for a combination treatment for acute myeloid leukemia.
Advertisement